CAS 376640-41-4

BVT 2733

CAS : 376640-41-4

Formule : C₁₇H₂₁ClN₄O₃S₂

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 428.9566

Ref: IN-DA00C6IP

BVT 2733

CAS : 376640-41-4

BVT 2733

Degré de pureté : ≥98%

Masse moléculaire : 428.96g/mol

Ref: 54-BUP15581

BVT 2733

CAS : 376640-41-4

BVT 2733

Degré de pureté : 98%

Masse moléculaire : 428.96g/mol

Ref: 54-BISN0019

BVT 2733

CAS : 376640-41-4

BVT 2733 is a new, non-steroidal, isoform-specific inhibitor of 11β-HSD1.

Formule : C₁₇H₂₁ClN₄O₃S₂

Degré de pureté : 98% - 99.64%

Couleur et forme : Solid

Masse moléculaire : 428.96

Ref: TM-T2057

BVT 2733

CAS : 376640-41-4

BVT 2733 is a drug that has been shown to have a metabolic effect on osteogenic genes. It is an inhibitor of the enzyme fatty acid synthase and has been shown to reduce the production of pro-inflammatory cytokines in adipose tissue, which may contribute to its anti-inflammatory properties. BVT 2733 also inhibits the synthesis of chemoattractant protein and polymerase chain reaction, which are involved in inflammatory bowel disease. This drug has been tested for pharmacokinetic properties, which have been found to be increased in cardiac and skin cells. The pharmacological activity of BVT 2733 is not fully understood yet; however, it has been shown to have glucocorticoid receptor agonist activity in vitro.

Formule : C₁₇H₂₁ClN₄O₃S₂

Degré de pureté : Min. 95%

Masse moléculaire : 429 g/mol

Ref: 3D-BB179811